References
-
1) Prucalopride might improve intestinal motility by promoting the regeneration of the enteric nervous system in diabetic rats.
Product: 5-HT-4 Antibody (#DF3503)Year: 2022Journal: INT J MOL MEDImpactFactor: 5.7DOI: 10.3892/ijmm.2022.5143PMID: 35543167 -
2) Bilirubin Induces Pain Desensitization in Cholestasis by Activating 5-Hydroxytryptamine 3A Receptor in Spinal Cord.
Product: 5-HT-4 Antibody (#DF3503)Year: 2021Journal: FRONT CELL DEV BIOLImpactFactor: 4.6DOI: 10.3389/fcell.2021.605855PMID: 33869168 -
3) Agomelatine rescues lipopolysaccharide-induced neural injury and depression-like behaviors via suppression of the Gαi-2-PKA-ASK1 signaling pathway.
Product: 5HT2C Receptor Antibody (#DF3501)Year: 2022Journal: J NEUROINFLAMMImpactFactor: 9.3DOI: 10.1186/s12974-022-02479-xPMID: 35610704 -
4) 5-HT1F Receptor Agonist Ameliorates Mechanical Allodynia in Neuropathic Pain via Induction of Mitochondrial Biogenesis and Suppression of Neuroinflammation.
Product: 5HT1F Receptor Antibody (#DF3499)Year: 2022Journal: FRONT PHARMACOLImpactFactor: 5.6DOI: 10.3389/fphar.2022.834570PMID: 35308244 -
5) Chidamide-Induced Accumulation of Reactive Oxygen Species Increases Lenalidomide Sensitivity Against Multiple Myeloma Cells.
Product: IKZF3 Antibody (#DF3472)Year: 2021Journal: ONCOTARGETS THERImpactFactor: 2.7DOI: 10.2147/OTT.S312249PMID: 34262292 -
6) Overexpression of U three protein 14a (UTP14a) is associated with poor prognosis of esophageal squamous cell carcinoma.
Product: UTP14A Antibody (#DF3418)Year: 2019Journal: THORAC CANCERImpactFactor: 2.3DOI: 10.1111/1759-7714.13176PMID: 31496055 -
7) Identification and validation of DLX4 as a prognostic and diagnostic biomarker for clear cell renal cell carcinoma.
Product: DLX4 Antibody (#DF3387)Year: 2023Journal: Oncol LettImpactFactor: 2.5DOI: 10.3892/ol.2023.13732PMID: 36936018 -
8) SIRT1 suppresses pituitary tumor progression by downregulating PTTG1 expression.
Product: GCN5L2 Antibody (#DF3383)Year: 2022Journal: ONCOL REPImpactFactor: 3.8DOI: 10.3892/or.2022.8354PMID: 35730625 -
9) Discovery of the Natural Bibenzyl Compound Erianin in Dendrobium Inhibiting the Growth and EMT of Gastric Cancer through Downregulating the LKB1-SIK2/3-PARD3 Pathway.
Product: PARD3 Antibody (#DF3368)Year: 2024Journal: Int J Mol SciImpactFactor: 5.6DOI: 10.3390/ijms25147973PMID: 39063214 -
10) Constitutive activation of β-catenin in odontoblasts induces aberrant pulp calcification in mouse incisors.
Product: PARD3 Antibody (#DF3368)Year: 2021Journal: J MOL HISTOLImpactFactor: 2.9DOI: 10.1007/s10735-021-09965-1PMID: 33689044 -
11) MiRNA-451a inhibits airway remodeling by targeting Cadherin 11 in an allergic asthma model of neonatal mice.
Product: CDH11 Antibody (#DF3523)Year: 2020Journal: INT IMMUNOPHARMACOLImpactFactor: 4.8DOI: 10.1016/j.intimp.2020.106440PMID: 32234673 -
12) BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo.
Product: CDH11 Antibody (#DF3523)Year: 2017Journal: MOL CARCINOGENImpactFactor: 3DOI: 10.1002/mc.22580PMID: 27770580 -
13) Qinzhuliangxue mixture ameliorates psoriasis by restraining apoptosis in psoriasis via downregulating the MDA-5 pathway.
Product: IFIH1 Antibody (#DF3423)Year: 2024Journal: J EthnopharmacolImpactFactor: 4.8DOI: 10.1016/j.jep.2024.118059PMID: 38508430 -
14) Comprehensive Analysis of the Transcriptome-Wide m6A Methylation Modification Difference in Liver Fibrosis Mice by High-Throughput m6A Sequencing.
Product: YTHDF1 Antibody (#DF3422)Year: 2021Journal: FRONT CELL DEV BIOLImpactFactor: 4.6DOI: 10.3389/fcell.2021.767051PMID: 34869362 -
15) LMTK2 regulates inflammation in lipopolysaccharide‑stimulated BV2 cells.
Product: LMTK2 Antibody (#DF3344)Year: 2021Journal: EXP THER MEDImpactFactor: 2.4DOI: 10.3892/etm.2021.9621PMID: 33603828